The Moving Average Convergence Divergence (MACD) for SURG turned positive on October 21, 2026. Looking at past instances where SURG's MACD turned positive, the stock continued to rise in 44 of 46 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on SURG as a result. In 73 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
SURG moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SURG crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +7.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in 203 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The 10-day RSI Indicator for SURG moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 30 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 41 cases where SURG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
SURG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SURG entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.425) is normal, around the industry mean (2.292). P/E Ratio (-0.111) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (8.005). Dividend Yield (0.000) settles around the average of (0.133) among similar stocks. P/S Ratio (0.048) is also within normal values, averaging (5.777).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where TGL declined for three days, in 297 of 309 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TGL entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for TGL just turned positive on October 26, 2026. Looking at past instances where TGL's MACD turned positive, the stock continued to rise in 23 of 30 cases over the following month. The odds of a continued upward trend are 77%.
Following a +6.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where TGL advanced for three days, in 117 of 150 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
TGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.023) is normal, around the industry mean (-1.906). P/E Ratio (-0.000) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (0.665) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. TGL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
SURG | ||
|---|---|---|
OUTLOOK RATING 1..100 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 10 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| SURG | TGL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 78% |
| Stochastic ODDS (%) | 2 days ago 90% | N/A |
| Momentum ODDS (%) | 2 days ago 81% | N/A |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| Advances ODDS (%) | 6 days ago 80% | 15 days ago 78% |
| Declines ODDS (%) | 9 days ago 88% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SURG’s FA Score shows that 2 FA rating(s) are green while TGL’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SURG’s TA Score shows that 5 TA indicator(s) are bullish while TGL’s TA Score has 4 bullish TA indicator(s).
SURG (@Major Telecommunications) experienced а +3.74% price change this week, while TGL (@Packaged Software) price change was -11.76% for the same time period.
The average weekly price growth across all stocks in the @Major Telecommunications industry was +1.56%. For the same industry, the average monthly price growth was +1.77%, and the average quarterly price growth was -6.47%.
The average weekly price growth across all stocks in the @Packaged Software industry was -2.44%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +4.03%.
SURG is expected to report earnings on Nov 11, 2026.
TGL is expected to report earnings on Nov 13, 2026.
Major telecommunications include companies that make communication possible across the globe – by providing voice and data transmission via multiple channels such as phone or the Internet, through airwaves or cables, through wires or wirelessly. The ease with which we connect with anyone, anywhere in the world is thanks in large part to the infrastructure created by the telecom industry. Some major telecom players include AT&T Inc., Verizon Communications Inc. and Nippon Telegraph and Telephone Corporation.
@Packaged Software (-2.44% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
A.I.dvisor indicates that over the last year, SURG has been loosely correlated with TGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SURG jumps, then TGL could also see price increases.
| Ticker / NAME | Correlation To SURG | 1D Price Change % | ||
|---|---|---|---|---|
| SURG | 100% | +3.46% | ||
| TGL - SURG | 37% Loosely correlated | -1.69% | ||
| RSKD - SURG | 36% Loosely correlated | N/A | ||
| RXT - SURG | 34% Loosely correlated | -1.47% | ||
| PCOR - SURG | 29% Poorly correlated | -0.26% | ||
| FIRY - SURG | 29% Poorly correlated | +5.23% | ||
More | ||||
A.I.dvisor indicates that over the last year, TGL has been loosely correlated with LAW. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TGL jumps, then LAW could also see price increases.
| Ticker / NAME | Correlation To TGL | 1D Price Change % | ||
|---|---|---|---|---|
| TGL | 100% | -1.69% | ||
| LAW - TGL | 46% Loosely correlated | +1.60% | ||
| SURG - TGL | 37% Loosely correlated | +3.46% | ||
| USIO - TGL | 36% Loosely correlated | -5.21% | ||
| CRNC - TGL | 31% Poorly correlated | -0.23% | ||
| DAVE - TGL | 30% Poorly correlated | -3.11% | ||
More | ||||